MAPT and Alzheimer disease: The lack of atrophy in the parietal lobe is logical, since this brain region is typically only affected in clinical stages of AD, and may be associated with the spread of tau pathology to widespread cortical areas (Johnson et al., 2016; Schöll et al., 2016).